TSXV:LITH
TSXV:LITHMetals and Mining

TSX Penny Stocks To Consider In July 2025

As the Canadian market navigates the complexities of new tariffs and shifting economic policies, investors are closely watching how these factors might influence various sectors. Penny stocks, often representing smaller or emerging companies, continue to capture interest due to their affordability and potential for growth. While the term may seem outdated, these stocks can still offer compelling opportunities when aligned with strong financial fundamentals.
NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue (NYSE:KVUE) Appoints Kirk Perry As Interim CEO For Transformation Initiative

Kenvue (NYSE:KVUE) recently experienced a 2% price increase over the past week, a move that coincides with notable executive changes. The replacement of the CEO with Kirk L. Perry as interim CEO, along with the company's strategic review, likely influenced investor sentiment. Meanwhile, broader market trends remained flat amid geopolitical uncertainties and cryptocurrency rallies, which added mixed sentiments to stock prices overall. Thus, while internal company changes contributed to...
NYSE:IONQ
NYSE:IONQTech

IonQ (NYSE:IONQ) Appoints Paul T. Dacier As New Chief Legal Officer

IonQ (NYSE:IONQ) recently appointed Paul T. Dacier as Chief Legal Officer, bringing his extensive legal experience to the company. Over the last quarter, IonQ's share price surged by 65%, a move potentially bolstered by executive changes and advancements in quantum technologies, such as their breakthrough in quantum simulation. Amid relatively stable market conditions, these developments could have provided additional momentum to IonQ's gains. While market uncertainty, particularly concerning...
TSX:WELL
TSX:WELLHealthcare

WELL Health Technologies (TSX:WELL) Extends Credit Facility To A$200 Million

WELL Health Technologies (TSX:WELL) recently announced an extension of its credit facility to a total of $200 million with significant available capacity, potentially reinforcing investor confidence and supporting a 19% share price increase in the past month. Additionally, the company's substantial expansion of primary care services, with capacity for over 45,000 new patients, aligns with its strategic goal to improve healthcare accessibility. Meanwhile, the broader market has remained...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Computing (NasdaqCM:RGTI) Completes $350M Equity Offering

Rigetti Computing (NasdaqCM:RGTI) experienced a notable share price movement, increasing by 41% over the last quarter. This shift coincided with its transition from value-oriented to growth-focused indexes, suggesting a re-evaluation of its market positioning. The company's strategic realignment under growth benchmarks appears to have played a role in this valuation change. While the broader market remained flat amid ongoing trade uncertainties, Rigetti's refined index listings and...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray Brands (NasdaqGS:TLRY) Soars 44% In Last Month

Tilray Brands (NasdaqGS:TLRY) saw its share price surge by 44% over the last month, a notable change considering recent corporate actions and external market dynamics. The recent announcements from Tilray Medical on cannabinoid formulations and the unveiling of a summer cannabis collection highlight the company's continuous product innovation, potentially attracting investor interest. However, the company's removal from several key indices and the pause on implementing a reverse stock split...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings (NasdaqCM:MARA) Sees New Chief Product Officer Appointment Shake-Up

MARA Holdings (NasdaqCM:MARA) experienced a 52% increase in its stock price over the last quarter, amid several key developments. The appointment of Nir Rikovitch as Chief Product Officer could strengthen product strategy and drive commercialization, potentially boosting investor confidence. The recent drop in MARA's index presence, alongside production inconsistencies, may counterbalance market optimism, but the strategic collaboration with TAE Power Solutions provides a positive outlook for...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

CleanSpark (NasdaqCM:CLSK) Sees 74% Stock Surge Over Last Quarter

CleanSpark (NasdaqCM:CLSK) recently highlighted its operational strength with significant bitcoin sales and production in June 2025, selling 579 bitcoin at a robust price point. Despite these achievements, the company faced the headwind of being dropped from several Russell Growth benchmarks and added to Value benchmarks. The company's share price experienced a remarkable 74% surge over the last quarter, aligning with broader market trends where the cryptocurrency sector saw gains as bitcoin...
TSX:BTO
TSX:BTOMetals and Mining

B2Gold (TSX:BTO) Reports Positive Feasibility Study For Gramalote With US$940 Million NPV

B2Gold (TSX:BTO) recently announced the successful results of a feasibility study for its Gramalote Gold Project in Colombia, which underscores its potential for strong economic returns and could have played a part in its 3% price increase over the last quarter. Additionally, the company's financial projections and strong community ties contribute positively to its image. Despite the broader market remaining flat and facing trade policy uncertainties, B2Gold's recent dividend affirmations and...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Enovix (NasdaqGS:ENVX) Expands Leadership in India with New R&D Head Appointment

Enovix (NasdaqGS:ENVX), recently experienced significant changes within its executive team, appointing Srikanth Kethu as Head of Enovix India on July 14, 2025, to bolster R&D and operational expansion in the region. Over the last quarter, the company saw a substantial increase in its share price by 134.11%, possibly influenced by multiple factors including the launch of the AI-1™ platform, financial updates indicating an improved net loss, and a $60 million share repurchase program. Despite...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Seattle University Chooses Workday (NasdaqGS:WDAY) to Enhance Campus Operations and Student Experience

Workday (NasdaqGS:WDAY) has been in the spotlight as Seattle University recently selected its solutions to enhance operations, which underscores the company's foothold in the educational sector. Despite this positive development, the company's share price saw a 4% decline over the last quarter. This movement could have been influenced by a mix of recent earnings, which showed a rise in revenue but a decline in net income, and ongoing market uncertainties related to U.S. trade policies. Market...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Quantum Computing (NasdaqCM:QUBT) Sees 155% Price Surge Over Last Quarter

Quantum Computing (NasdaqCM:QUBT) has seen a significant surge in its stock price, climbing 155% over the last quarter. This remarkable growth coincided with the company's inclusion in multiple Russell indices, which likely enhanced its visibility and attractiveness to investors. Additionally, the successful private placement that raised $20 million and the strategic appointment of a new CFO, Christopher Roberts, could have reinforced positive investor sentiment. The shipment of a commercial...
NYSE:ARE
NYSE:AREHealth Care REITs

Alexandria Real Estate Equities (NYSE:ARE) Secures Largest Life Science Lease in History

Alexandria Real Estate Equities (NYSE:ARE) recently secured a significant 16-year lease for a massive research hub in their San Diego megacampus, marking the largest life science lease in the company's history. This event underscores strong demand within the life science real estate sector, potentially supporting the company's 10% share price increase over the past month. During this time, while major indexes remained near all-time highs despite trade uncertainties, Alexandria's expansion...
LSE:AZN
LSE:AZNPharmaceuticals

AstraZeneca (LSE:AZN) Unveils Promising Phase III Results For Baxdrostat In Hypertension Trial

AstraZeneca (LSE:AZN) recently experienced a weekly price move of 2% amid announcements that could have supported its momentum. The successful Phase III trial results for Baxdrostat, targeting a significant global need for hypertension treatments, likely provided a positive catalyst. Additionally, the European Union's approval of Imfinzi for a new cancer indication may have added further support. These developments occurred against a backdrop of flat overall market performance, with major...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck (NYSE:MRK) Partners With Gates Foundation For HIV PrEP Trials In 16 Countries

Merck (NYSE:MRK) recently announced the initiation of its Phase 3 EXPrESSIVE clinical trials for MK-8527, a new HIV prevention drug, reflecting its commitment to addressing global health challenges. Over the past quarter, the company’s stock saw a price increase of 6%. Despite a flat broader market largely unaffected by geopolitical trade uncertainties, Merck's progress in clinical trials and the partnership with the Gates Foundation might have provided additional optimism among investors...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Huntington Bancshares (NasdaqGS:HBAN) Acquires Veritex Holdings for Strategic Expansion

Huntington Bancshares (NasdaqGS:HBAN) gained 30% last quarter, a significant increase in a period marked by its acquisition of Veritex Holdings, which may reshape its growth trajectory. This acquisition could be seen as aligning with investors' bullish sentiment as major stock indices neared record highs despite trade policy uncertainties. Additionally, Huntington's strong Q1 earnings, highlighted by a rise in net interest income and net income, likely supported its positive performance. The...